Legend Biotech (LEGN) Work In Process (2022 - 2025)
Legend Biotech (LEGN) reported Work In Process of $4.9 million for Q1 2025, up 86.79% on a YoY basis from $2.6 million in Q1 2024, and up 11.1% quarter-over-quarter from $4.4 million in Q4 2024.
Legend Biotech (LEGN) Work In Process (2022 - 2025) Analysis & Trends
Legend Biotech has reported Work In Process for 4 years, with the latest figure at $4.9 million in Q1 2025.
- For the quarter ending Q1 2025, Work In Process rose 86.79% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2025 stood at $4.9 million (up 86.79% YoY), and the FY2024 full-year result was $4.4 million, up 48.49% from the prior year.
- Work In Process for Q1 2025 stood at $4.9 million, up from $4.4 million in the prior quarter.
- The five-year high for Work In Process was $4.9 million in Q3 2024, with the low at $690000.0 in Q4 2022.
- Historically, Work In Process has averaged $3.3 million across 4 years, with a median of $3.0 million in 2023.
- Annual changes were most pronounced in 2023 — Work In Process jumped 333.33% — and 2024, when it jumped 48.49%.
- Legend Biotech's Work In Process stood at $690000.0 in 2022, then jumped by 333.33% to $3.0 million in 2023, then surged by 48.49% to $4.4 million in 2024, then rose by 11.1% to $4.9 million in 2025.
- The last three Work In Process figures came in at $4.9 million (Q1 2025), $4.4 million (Q4 2024), and $4.9 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.93 Mn |
| Dec 31, 2024 | 4.44 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | 2.99 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Jun 30, 2023 | 2.14 Mn |
| Dec 31, 2022 | 690,000.00 |